BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Abbas Z, Siddiqui AR. Management of hepatitis B in developing countries. World J Hepatol 2011; 3(12): 292-299 [PMID: 22216369 DOI: 10.4254/wjh.v3.i12.292]
URL: https://www.wjgnet.com/1948-5182/full/v3/i12/292.htm
Number Citing Articles
1
Mohammad Hossein Somi, Babak Hajipour. Improving Hepatitis B Vaccine Efficacy in End-Stage Renal Diseases Patients and Role of AdjuvantsISRN Gastroenterology 2012; 2012: 1 doi: 10.5402/2012/960413
2
Engy Mohamed El-Ghitany, Azza Galal Farghaly. Evaluation of commercialized rapid diagnostic testing for some Hepatitis B biomarkers in an area of intermediate endemicityJournal of Virological Methods 2013; 194(1-2): 190 doi: 10.1016/j.jviromet.2013.08.026
3
Suh Kuan Yong, Shang-Kai Shen, Chia-Wei Chiang, Ying-Ya Weng, Ming-Pei Lu, Yuh-Shyong Yang. Silicon Nanowire Field-Effect Transistor as Label-Free Detection of Hepatitis B Virus Proteins with Opposite Net ChargesBiosensors 2021; 11(11): 442 doi: 10.3390/bios11110442
4
Xuefen Li, Xia Liu, Li Tian, Yu Chen. Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus InfectionsClinical Reviews in Allergy & Immunology 2016; 50(1): 41 doi: 10.1007/s12016-014-8465-4
5
Gourdas Choudhuri, Varun Gupta, Tajinder Singh Negi, Rajesh Ojha. Potential Implications of Detecting HBsAg in Asymptomatic People in an Endemic Community Through Medical CampsJournal of Clinical and Experimental Hepatology 2019; 9(1): 43 doi: 10.1016/j.jceh.2018.02.005
6
Francesca Cainelli. Liver diseases in developing countriesWorld Journal of Hepatology 2012; 4(3): 66-67 doi: 10.4254/wjh.v4.i3.66
7
Mi Na Kim, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Kwang‐Hyub Han. Durability of the virological response after lamivudine discontinuation in lamivudine‐resistant patients with a complete virological response after lamivudine and adefovir combination therapyJournal of Medical Virology 2017; 89(1): 85 doi: 10.1002/jmv.24616
8
Lourdes Maria Pinheiro Borzacov, Larissa Deadame de Figueiredo Nicolete, Luan Felipo Botelho Souza, Alcione Oliveira dos Santos, Deusilene Souza Vieira, Juan Miguel Villalobos Salcedo. Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavirInternational Journal of Infectious Diseases 2016; 46: 82 doi: 10.1016/j.ijid.2016.03.017
9
Hailay Kinfe, Endalew Gemechu Sendo, Ketema Bizuwork Gebremedhin. Prevalence of Hepatitis B Virus Infection and Factors Associated with Hepatitis B Virus Infection Among Pregnant Women Presented to Antenatal Care Clinics at Adigrat General Hospital in Northern EthiopiaInternational Journal of Women's Health 2021; : 119 doi: 10.2147/IJWH.S280806
10
Thieu Le, Thuc Vu, Hue Mai, Long Nguyen, Nu Truong, Chi Hoang, Son Nguyen, Cuong Nguyen, Binh Nguyen, Tung Tran, Bach Tran, Carl Latkin, Cyrus Ho, Roger Ho. Social Determinants of Stigma and Discrimination in Vietnamese Patients with Chronic Hepatitis BInternational Journal of Environmental Research and Public Health 2019; 16(3): 398 doi: 10.3390/ijerph16030398
11
Alireza Ansari-Moghaddam, Hossein Ansari, Soheila Khosravi, Esmail Sanei-Moghaddam, Mahdi Mohammadi, Seyed Moayed Alavian, Hossein Poustchi. The Prevalence of Hepatitis B Virus Among Municipal Solid Waste Workers: Necessity for Immunization of At-Risk GroupsHepatitis Monthly 2016; 16(3) doi: 10.5812/hepatmon.30887
12
Amol Prabhakar Patil, Ebby George Simon, Amit Kumar Dutta, Anjilivelil Joseph Joseph, Reuben Thomas Kurien, Sudipta Dhar Chowdhury. Prevalence of serological markers of hepatitis B in inflammatory bowel disease – Experience from a tertiary care centre in South IndiaTropical Doctor 2021; 51(3): 326 doi: 10.1177/00494755211015571
13
En Qiang Chen, Lang Bai, Lan Lan Chen, Tao You Zhou, Ling Yao Du, Hong Tang. Prolonged Combination Therapy is More Effective than Monotherapy in Management of Chronic Hepatitis B Patients With Sustained Virological Response: An Experience From a ‘Real-World’ Clinical SettingIranian Red Crescent Medical Journal 2013; 15(12) doi: 10.5812/ircmj.7788
14
Chen Huang, Cong Li, Feng Liu, Ruofei Xu. Vaccination and risky behaviors: evidence from the hepatitis B vaccination campaign in ChinaJournal of Population Economics 2023; 36(4): 2549 doi: 10.1007/s00148-023-00942-4
15
Sung Bae Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han. Outcome of adefovir add‐on lamivudine rescue therapy of up to 5 years in patients with lamivudine‐resistant chronic hepatitis BJournal of Gastroenterology and Hepatology 2016; 31(1): 241 doi: 10.1111/jgh.13046
16
Yoshihiko Yano, Takako Utsumi, Maria Inge Lusida, Yoshitake Hayashi. Hepatitis B virus infection in IndonesiaWorld Journal of Gastroenterology 2015; 21(38): 10714-10720 doi: 10.3748/wjg.v21.i38.10714
17
Hengxin Li, Jun Chen, RuiZhi Zhang, Ran Xu, Zhe Zhang, Le Ren, Qi Yang, Yumei Tian, Daxu Li. Single nucleotide polymorphisms in ZNF208 are associated with increased risk for HBV in Chinese peopleOncotarget 2017; 8(68): 112451 doi: 10.18632/oncotarget.19669
18
Andrew Hill, Dzintars Gotham, Graham Cooke, Sanjay Bhagani, Isabelle Andrieux-Meyer, Jennifer Cohn, Joseph Fortunak. Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countriesJournal of Virus Eradication 2015; 1(2): 103 doi: 10.1016/S2055-6640(20)30484-2
19
Shigui Yang, Cheng Ding, Yuanxia Cui, Jie Wu, Chengbo Yu, Ping Chen, Kaijin Xu, Min Deng, Yiping Li, Juanjuan Liu, Pei Yin, Wen Ren, Yan Qiu, Qing Cao, Yuqing Zhou, Jun Yao, Bing Ruan, Jingjing Ren, Lanjuan Li. Prevalence and influencing factors of hepatitis B among a rural residential population in Zhejiang Province, China: a cross-sectional studyBMJ Open 2017; 7(4): e014947 doi: 10.1136/bmjopen-2016-014947
20
Aswin Damodaran, Subin Mary Zachariah, Sreeja Chandrasekharan Nair. Novel therapeutic approaches for the management of hepatitis infectionsTherapeutic Delivery 2024; 15(3): 211 doi: 10.4155/tde-2023-0074
21
Abbas Umer, Zelalem Teklemariam, Firayad Ayele, Melkamu Merid Mengesha. Prevalence of hepatitis B infection and its associated factors among pregnant mothers attending antenatal care at public hospitals at Hararghe, Eastern EthiopiaFrontiers in Global Women's Health 2023; 4 doi: 10.3389/fgwh.2023.1056488
22
Muhammad Rezki, Ni Luh Wulan Septiani, Muhammad Iqbal, Suksmandhira Harimurti, Poetro Sambegoro, Damar Rastri Adhika, Brian Yuliarto. Amine-functionalized Cu-MOF nanospheres towards label-free hepatitis B surface antigen electrochemical immunosensorsJournal of Materials Chemistry B 2021; 9(28): 5711 doi: 10.1039/D1TB00222H
23
Vincent Soriano, Brian McMahon. Strategic use of lamivudine in the management of chronic hepatitis BAntiviral Research 2013; 100(2): 435 doi: 10.1016/j.antiviral.2013.08.026
24
Seo Jin Hong, Min Hye Ahn, Yong Woo Lee, Sukdeb Pal, Jaiprakash Sangshetti, Rohidas B. Arote. Cutting-Edge Enabling Technologies for Regenerative MedicineAdvances in Experimental Medicine and Biology 2018; 1078: 303 doi: 10.1007/978-981-13-0950-2_16
25
Jean-Pierre Allain, Ohene Opare-Sem. Screening and diagnosis of HBV in low-income and middle-income countriesNature Reviews Gastroenterology & Hepatology 2016; 13(11): 643 doi: 10.1038/nrgastro.2016.138
26
Si‐hui Hou, Jun Hu, Yu Zhang, Qing‐Ling Li, Jin‐Jun Guo. Effects of interaction between genetic variants in human leukocyte antigen DQ and granulysin genes in Chinese Han subjects infected with hepatitis B virusMicrobiology and Immunology 2015; 59(4): 209 doi: 10.1111/1348-0421.12239